4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-057671
See Remarks sold 2,553 shares at $12.01 ($30,662)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scalzo Richard William See Remarks | 2023-12-04 | Sale 10b5-1 | −681 | $12.01 | $8,179 | 129,856 | D |
| Scalzo Richard William See Remarks | 2023-12-06 | Sale 10b5-1 | −1,872 | $12.01 | $22,483 | 127,984 | D |
| Open-market sales · 2,553 sh · avg $12.01 · $30,662 | |||||||
Loading xslF345X05/doc4.xml…